DECEMBER 2018CIOAPPLICATIONS.COM6DECEMBER - 03 - 2018BIOTECHNOLOGY SPECIALCopyright © 2018 ValleyMedia, Inc. All rights reserved. Reproduction in whole or part of any text, photography or illustrations without written permission from the publisher is prohibited. The publisher assumes no responsibility for unsolicited manuscripts, photographs or illustrations. Views and opinions expressed in this publication are not necessarily those of the magazine and accordingly, no liability is assumed by the publisher thereof.Graphics & ArtDeclan ColeAnil KumarSalesGeorge Thomasgeorge@cioapplicatons.comEditorialThe Dynamic and Challenging World of BiotechJoe PhillipManaging Editoreditor@cioapplications.comJoe PhillipThe biotech industry is being influenced by an unprecedented level of innovations with new technologies such as gene therapy. However, the sector is also facing several challenges ranging from cost and pricing pressures to loss of patent protection and the uncertainties of healthcare reforms. Subsequently, the industry has responded by creating novel approaches to treat diseases and developing new drug delivery techniques. A number of biotech companies tend to outsource most of their development and manufacturing operations. One of the key drivers of outsourcing is the rising cost to develop and manufacture new drugs, hence creating the demand for contract development and manufacturing organizations with a wide range of capabilities. The large and mid-size pharmaceutical companies, on the other hand, constantly face the pressure to refill their drug pipeline. To do so, they rely on acquisitions or in-licensing from smaller biotech companies to gain access to innovation and more innovative drug candidates. Further, due to the ever-increasing costs of bringing drugs to market, larger pharma and biotech companies are constantly probing for manufacturing strategies to realize more effective development and manufacturing operations. There is an ongoing demand for increased production efficiency not only from a technological aspect but also in terms of the yield of high-value products. Today, biotech customers expect a great deal of oversight to realize the necessary and requested high quality of their products. With the many challenges affecting the biotech industry, outsourcing various development and manufacturing operations is expected to continue, especially with the increasing number of smaller companies striving to enter the market and have their innovative products move through the development process as quickly as possible. There is little doubt that the market will continue to grow, and this growth offers promising opportunities for those solution providers that are well-orchestrated and prepared to meet the needs of their large and small biotech customers today and in the future. This special edition features articles from industry experts and innovative solution providers in the biotech space to help you make informed decisions for your enterprise.Let us know your thoughts. Managing EditorJoe PhillipEditorial StaffBen JacksonDaniel HolmesD Ashwani KumarNaomi DaleSamikshya Behera*Some of the Insights are based on the interviews with respective CIOs and CXOs to our editorial staffVolume 03 - 54Published by ValleyMedia, Inc. To subscribe to CIO ApplicationsVisit www.cioapplications.com Emailsales@cioapplications.comeditor@cioapplications.commarketing@cioapplications.comContact UsPhone: 510.757.1040Fax: 510.894.8405
< Page 5 | Page 7 >